- Ryogen Licenses Human Aminopeptidase P Gene Patent To OriGene Technologies
Ryogen LLC (Ryogen) headquartered in Suffern, NY and OriGene Technologies Inc., of Rockwell, MD (OriGene) announced today that they have entered into a nonexclusive license agreement whereby OriGene has licensed from Ryogen the patent directed to the clinically important Aminopeptidase P gene. - Scans Today Give A Crisp Picture Of Your Body's Inner Workings
A decade or two ago, if your doctor had said, “Let's take a peek inside,” you would have known you were facing exploratory surgery. But today, more than likely your doctor is referring to one of the scans that can show the inner workings of your body in precise detail. And for most of them, you won't feel a thing. Depending on your symptoms or condition, your doctor might recommend: - Virtual Radiologic Files Registration Statement With The SEC For An Initial Public Offering
Virtual Radiologic Corporation (the "Company") announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. - Given Imaging Announces French Health System Completes First Step In Covering PillCam(TM)
Imaging Ltd. (NASDAQ: GIVN) today announced that the French National Authority for Health (HAS) has completed the first step in advancing universal reimbursement for PillCam SB capsule endoscopy for over 60 million French citizens. In late July, the HAS published a report that highly recommends the use of PillCam SB in patients with obscure gastro-intestinal bleeding and Crohn's disease following inconclusive first-line tests. - Spinoff Company Based On Technology Developed At OHSU Enters New Business Phase
A spin-off company based on technology developed by an Oregon Health & Science University researcher has reached an important business milestone. The Portland-based company, called AMES Technology, will use an anonymous $1.7 million investment to begin clinical trials of its stroke rehabilitation technology while developing products for clinical use and sale. The stock received for this investment also was donated to OHSU to support neuroscience research at its Neurological Sciences Institute. - Appropriateness Criteria Issued For Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging
The American College of Cardiology Foundation (ACCF) along with key specialty and subspecialty societies have released Appropriateness Criteria for two relatively new clinical cardiac imaging modalities, cardiac computed tomography (CCT) and cardiac magnetic resonance imaging (CMR). These Criteria were developed in order to address the growth in biomedical imaging to ensure that it is appropriate to patient needs. - EcoArray Announces New Technology For Environmental Testing
EcoArray, Inc. announced today the release of its 22,000-gene microarray in Fathead minnows designed for research and use in environmental toxicology. The array is available immediately. It is manufactured by Agilent Technologies using its custom oligonucleotide microarray platform. - Current Technology For Brain Cooling Unlikely To Help Trauma Patients
Attempts to cool the brain to reduce injury from stroke and other head trauma may face a significant obstacle: current cooling devices can't penetrate very deeply into the brain. - University ‘spin-out' To Revolutionise Biomedical Optics
Kent Enterprise and the School of Physical Sciences at the University of Kent have ‘spun out' a high-tech company that is set to revolutionise biomedical optics. - The Cost Of Pollution At Southern California Beaches
Removing fecal contamination from the waters off Southern California beaches could prevent up to 1.5 million cases of gastrointestinal illness among swimmers and other recreational water users annually, a new study has found. It is scheduled for publication in the Aug. 15 issue of ACS' Environmental Science & Technology. - Hologic To Present At Canaccord Adams 26th Annual Summer Seminar
BEDFORD, Mass., Aug. 2 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Jack Cumming, Chairman and Chief Executive Officer, and Rob Cascella, President and Chief Operating Officer, will be presenting at the Canaccord Adams Summer Seminar being held August 8-10, 2006 at the Boston Marriott Long Wharf Hotel in Boston, MA. - Telzuit Medical Technologies Acquires Mobile Medical Imaging Company PDS Imaging
Telzuit Medical Technologies, Inc. (OTC Bulletin Board: TZMT) announced today that it has acquired Florida-based mobile ultrasound and cardiac imaging company PDS Imaging (PDS). The transaction, which closed August 1, 2006, was financed through a combination of cash and Telzuit common stock. Terms of the transaction were not disclosed. - 3-D Images Of Knees Built Quickly With New MRI Technique
A faster magnetic resonance imaging (MRI) data-acquisition technique will cut the time many patients spend in a cramped magnetic resonance scanner, yet deliver more precise 3-D images of their bodies. - Olympus Acquires Single Module Fluorescence Spectroscopy Technology And IP Portfolio From Evotec
Olympus has acquired technology and patents for single molecule fluorescence spectroscopy from Evotec Technologies of Germany. - Progress Report On Homogeneous Assay Project
International medical diagnostics company Panbio Limited today announced that it has achieved some encouraging results in the development of its Homogeneous Assay Technology.
|
